STOCK TITAN

Cineverse (CNVS) CEO exercises 40,000 RSUs and updates equity stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cineverse Corp. director, CEO and Chairman Christopher J. McGurk reported an update to his equity holdings, including an option-style transaction. He exercised derivative securities labeled as restricted stock units to acquire 40,000 shares of Class A common stock at a stated price of $0.0000 per share, increasing his direct ownership of common stock to 582,519 shares.

He also reports 178,526 shares of Class A common stock held indirectly through the Christopher and Jamie McGurk Living Trust, where he serves as trustee. In addition, he continues to hold several derivative awards tied to Class A common stock, including restricted stock units covering 263,006 and 50,000 underlying shares and stock appreciation rights over 125,000, 125,000 and 35,000 underlying shares at exercise prices of $9.60, $10.80 and $29.40 with stated vesting and expiration schedules.

Positive

  • None.

Negative

  • None.
Insider MCGURK CHRISTOPHER J
Role CEO and Chairman
Type Security Shares Price Value
Exercise Restricted Stock Unit 40,000 $0.00 --
Exercise Class A Common Stock 40,000 $0.00 --
holding Stock Appreciation Right -- -- --
holding Stock Appreciation Right -- -- --
holding Stock Appreciation Right -- -- --
holding Restricted Stock Unit -- -- --
holding Restricted Stock Unit -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 80,000 shares (Direct, null); Class A Common Stock — 582,519 shares (Direct, null); Stock Appreciation Right — 35,000 shares (Direct, null); Class A Common Stock — 178,526 shares (Indirect, By Christopher and Jamie McGurk Living Trust)
Footnotes (1)
  1. Includes 50,000 shares of restricted stock that vest on April 25, 2027. The reporting person is a trustee of the Christopher and Jamie McGurk Living Trust. One-third of the stock appreciation rights vested on March 31 of each of 2019, 2020 and 2021. 62,500 of the stock appreciation rights vested on November 19, 2020 and 62,500 of the stock appreciation rights vested on March 31, 2023. Of the stock appreciation rights, 41,666 vested on April 1, 2023, 41,666 vested on April 1, 2024 and 41,668 vested on April 1, 2025. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 41,666 vest on April 25, 2027. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 40,000 vested on May 1, 2026, and 40,000 vest on May 1 of each of 2027 and 2028. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 87,669 vest on October 8 of each of 2026 and 2027 and 87,668 vest on October 8, 2028.
RSUs exercised 40,000 shares Restricted stock units converted into Class A common stock on May 1, 2026
Direct common stock holding 582,519 shares Class A common stock directly owned following the derivative exercise
Indirect trust holding 178,526 shares Class A common stock held by Christopher and Jamie McGurk Living Trust
RSU position 1 263,006 underlying shares Restricted stock units, each equal to one Class A share
RSU position 2 50,000 underlying shares Restricted stock units vesting including 50,000 shares on April 25, 2027
SARs at $9.60 125,000 underlying shares Stock appreciation rights with $9.60 exercise price, expiring October 17, 2032
SARs at $10.80 125,000 underlying shares Stock appreciation rights with $10.80 exercise price, expiring November 19, 2030
SARs at $29.40 35,000 underlying shares Stock appreciation rights with $29.40 exercise price, expiring June 7, 2028
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" and footnotes stating each unit equals one share of Class A common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Appreciation Right financial
"security_title: "Stock Appreciation Right" with exercise prices of 9.6000, 10.8000 and 29.4000 and stated expiration dates."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for the M‑coded transactions."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
"direct_or_indirect: "I" and nature_of_ownership: "By Christopher and Jamie McGurk Living Trust"."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCGURK CHRISTOPHER J

(Last)(First)(Middle)
C/O CINEVERSE CORP.
224 W. 35TH STREET, SUITE 500, #947

(Street)
NEW YORK NEW YORK 10001

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cineverse Corp. [ CNVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock05/01/2026M40,000A(7)582,519(1)D
Class A Common Stock178,526IBy Christopher and Jamie McGurk Living Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Appreciation Right$29.4 (3)06/07/2028Class A Common Stock35,00035,000D
Stock Appreciation Right$10.8 (4)11/19/2030Class A Common Stock125,000125,000D
Stock Appreciation Right$9.6 (5)10/17/2032Class A Common Stock125,000125,000D
Restricted Stock Unit(6) (6) (6)Class A Common Stock50,00050,000D
Restricted Stock Unit(7)05/01/2026M40,000 (7) (7)Class A Common Stock40,000$080,000D
Restricted Stock Unit(8) (8) (8)Class A Common Stock263,006263,006D
Explanation of Responses:
1. Includes 50,000 shares of restricted stock that vest on April 25, 2027.
2. The reporting person is a trustee of the Christopher and Jamie McGurk Living Trust.
3. One-third of the stock appreciation rights vested on March 31 of each of 2019, 2020 and 2021.
4. 62,500 of the stock appreciation rights vested on November 19, 2020 and 62,500 of the stock appreciation rights vested on March 31, 2023.
5. Of the stock appreciation rights, 41,666 vested on April 1, 2023, 41,666 vested on April 1, 2024 and 41,668 vested on April 1, 2025.
6. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 41,666 vest on April 25, 2027.
7. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 40,000 vested on May 1, 2026, and 40,000 vest on May 1 of each of 2027 and 2028.
8. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 87,669 vest on October 8 of each of 2026 and 2027 and 87,668 vest on October 8, 2028.
/s/ Christopher J. McGurk05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cineverse (CNVS) disclose for CEO Christopher McGurk?

Cineverse disclosed that CEO Christopher J. McGurk exercised derivative securities classified as restricted stock units to acquire 40,000 shares of Class A common stock at a stated price of $0.0000 per share, increasing his directly held common stock position reported in this filing.

How many Cineverse (CNVS) shares does the CEO hold directly after this Form 4?

After the reported derivative exercise, Christopher J. McGurk holds 582,519 shares of Cineverse Class A common stock directly. This figure reflects his post-transaction ownership as shown in the filing’s non-derivative section for Class A common stock on the reported transaction date.

What indirect Cineverse (CNVS) holdings are reported through the McGurk trust?

The filing shows 178,526 shares of Cineverse Class A common stock held indirectly through the Christopher and Jamie McGurk Living Trust. A footnote states that McGurk is a trustee of this trust, providing additional context for the indirect ownership classification.

What restricted stock units does the Cineverse (CNVS) CEO still hold?

The filing lists restricted stock units tied to 263,006 and 50,000 underlying shares of Cineverse Class A common stock. Footnotes explain that each unit equals one share, with portions vesting on dates such as October 8, 2026–2028 and April 25, 2027, among others.

What stock appreciation rights are outstanding for the Cineverse (CNVS) CEO?

McGurk holds stock appreciation rights over 125,000 shares at a $9.60 exercise price, 125,000 shares at $10.80, and 35,000 shares at $29.40. Footnotes describe prior vesting installments and list expiration dates extending to 2028, 2030, and 2032.

Does this Cineverse (CNVS) Form 4 show any open-market share sales or purchases?

The summarized data show a derivative exercise labeled with code M for 40,000 shares and several holding entries, but no open-market purchase or sale codes. The transactionSummary indicates zero buy and sell transactions, focusing instead on an exercise of derivative securities.